Leadership Team

Vik Krishnan is Instem’s CEO, guiding our vision to be the leading SaaS platform in preclinical life sciences. With extensive expertise in digital transformation and life sciences, Vik is dedicated to advancing Instem’s mission to enable clients to accelerate drug discovery and manage study data more effectively. He leads the organization with a focus on strategic growth, innovation, and fostering strong client relationships across the global life sciences sector.

Donna Robinson is Instem’s Chief Commercial Officer, bringing over 20 years of expertise in healthcare technology, strategic sales, and customer engagement. With a proven track record of driving sustained growth and delivering impactful client solutions, Donna leads Instem’s commercial and sales strategy, supporting clients worldwide in optimizing their research and development workflows. Her focus on client success and strategic partnerships ensures that Instem delivers exceptional value across the preclinical landscape.

Mike Ryan is Instem’s Chief Strategy & Transformation Officer, leveraging more than two decades of expertise in strategic operations, sales transformation, and program management. Known for his impactful leadership in executing high-growth initiatives, Mike drives Instem’s strategic direction to enhance efficiency, scalability, and market presence. His approach integrates operational excellence with a focus on aligning Instem’s strategy to meet client needs and achieve transformative results across the organization.

Louis Brook is Instem’s Chief Technology Officer, responsible for leading technology strategy, digital transformation, and IT innovation. With over 20 years of experience in technology leadership, digital strategy, and security, Louis ensures that Instem’s technology infrastructure supports its growth ambitions and enhances customer value. His expertise in scalable technology solutions and agile transformation fosters operational efficiency and strengthens Instem’s competitive edge in the life sciences industry.

Eve Leconte is Instem’s Chief Administrative Officer, dedicated to cultivating a dynamic, inclusive workplace where talent thrives. With extensive experience in human resources leadership, talent management, and organizational development, Eve drives initiatives that support Instem’s people-centred growth and cultural transformation. Her focus on fostering employee engagement, development, and diversity empowers the Instem team to deliver on its mission with passion and purpose.

Gina Green is Instem’s Chief Delivery Officer, with over 20 years of experience successfully delivering client projects across the preclinical landscape. Known for her expertise in service excellence and operational efficiency, Gina leads Instem’s global service delivery strategy, ensuring clients achieve impactful outcomes. Her role as an adjunct professor enriches her approach, as she shares her industry insights and passion for operational excellence with both the Instem team and emerging leaders.

Joe Pisciotta is Instem’s Chief Financial Officer, responsible for leading the company’s global financial strategy, planning, and operational performance. With extensive experience in financial leadership across technology-enabled services and private equity-backed organizations, Joe brings a strong track record of driving growth, operational discipline, and strategic transformation.

Joe works closely with Instem’s executive team to support the company’s long-term growth ambitions, ensuring strong financial governance while enabling continued investment in innovation and client success. His expertise in complex financial operations, mergers and acquisitions, and scaling global businesses helps position Instem for sustained expansion in the life sciences technology sector.

Stephen Baker is Instem’s Senior Vice President of Clinical Trial Acceleration, driving initiatives to streamline clinical research and enhance data-sharing capabilities. With extensive expertise in life sciences technology and strategic sales, Stephen is committed to advancing Instem’s mission to accelerate drug development and optimize study management. He leads with a focus on innovation, operational excellence, and building impactful client partnerships across the global clinical research industry.

Beth Hazell is Instem’s Chief Product Officer, responsible for leading the development and execution of the company’s product vision, strategy, and roadmap, ensuring alignment with broader business objectives. With over 20 years of experience in product management, marketing, and business strategy, Beth is a seasoned executive known for driving innovation and delivering impactful product initiatives in the life sciences and laboratory informatics sectors. Her expertise lies in aligning product strategies with business goals to create market-leading solutions that meet current customer needs while anticipating future trends.